BIOMAT Database Logo BIOMAT Database Logo

[Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy]. 1986

M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D011115 Polyneuropathies Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance. Polyneuropathy, Acquired,Polyneuropathy, Critical Illness,Polyneuropathy, Familial,Polyneuropathy, Inherited,Polyneuropathy, Motor,Acquired Polyneuropathies,Acquired Polyneuropathy,Critical Illness Polyneuropathies,Critical Illness Polyneuropathy,Familial Polyneuropathies,Familial Polyneuropathy,Inherited Polyneuropathies,Inherited Polyneuropathy,Motor Polyneuropathies,Motor Polyneuropathy,Polyneuropathies, Acquired,Polyneuropathies, Critical Illness,Polyneuropathies, Familial,Polyneuropathies, Inherited,Polyneuropathies, Motor,Polyneuropathy
D011756 Diphosphates Inorganic salts of phosphoric acid that contain two phosphate groups. Diphosphate,Pyrophosphate Analog,Pyrophosphates,Pyrophosphate Analogs,Analog, Pyrophosphate
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D005260 Female Females
D005710 Gallium Radioisotopes Unstable isotopes of gallium that decay or disintegrate emitting radiation. Ga atoms with atomic weights 63-68, 70 and 72-76 are radioactive gallium isotopes. Radioisotopes, Gallium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.
March 1987, American heart journal,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Study of combined technetium 99m methylene diphosphonate and gallium 67 citrate scintigraphy in diffuse sclerosing osteomyelitis of the mandible: case reports.
August 1991, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis.
November 1984, The American journal of cardiology,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma.
July 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Negative myocardial technetium-99m pyrophosphate scintigraphy in amyloid heart disease associated with type AA systemic amyloidosis.
January 1984, The American journal of cardiology,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Gallium-67/technetium-99m methylene diphosphonate ratio imaging: early rabbit osteomyelitis and fracture.
March 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Technetium-99m methylene diphosphonate scintigraphy of relapsing polychondritis.
September 1991, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
[Technetium 99m pyrophosphate scintigraphy in cardiac amyloidosis].
September 1988, Presse medicale (Paris, France : 1983),
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Intense myocardial uptake of gallium-67 citrate and technetium-99m pyrophosphate in a uremic patient.
October 1985, Clinical nuclear medicine,
M Hongo, and T Misawa, and H Yamada, and J Hirayama, and S Okubo, and T Fujii, and S Kusama, and S Ikeda
Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography.
October 1993, The American journal of cardiology,
Copied contents to your clipboard!